Return to see the world's first patient treated with a new 'dual vector' gene therapy for a rare genetic disease that also ...

This is a huge step forward in the genetic treatment of deafness, one that can be life-changing for children and adults,” the study’s lead author said.

Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...

Zacks Equity Research shares Vital Farms VITL as the Bull of the Day and Centrus Energy LEU as the Bear of the Day. In addition, Zacks Equity ...

The HHS is betting $500 million on developing a universal flu vaccine that could protect against multiple flu strains.

The FDA had asked Sarepta to voluntarily halt all shipments of Elevidys following the deaths of three nonambulatory Duchenne ...

This complicated system has within it certain bacteria that use tail-like structures called “flagella to move, releasing an ...